Antisense PMO Found in Dystrophic Dog Model Was Effective in Cells from Exon 7-Deleted DMD Patient

BACKGROUND: Antisense oligonucleotide-induced exon skipping is a promising approach for treatment of Duchenne muscular dystrophy (DMD). We have systemically administered an antisense phosphorodiamidate morpholino oligomer (PMO) targeting dystrophin exons 6 and 8 to a dog with canine X-linked muscula...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Takashi, Nakamura, Akinori, Aoki, Yoshitsugu, Yokota, Toshifumi, Okada, Takashi, Osawa, Makiko, Takeda, Shin'ichi
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923599/
https://www.ncbi.nlm.nih.gov/pubmed/20805873
http://dx.doi.org/10.1371/journal.pone.0012239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923599/
https://www.ncbi.nlm.nih.gov/pubmed/20805873
http://dx.doi.org/10.1371/journal.pone.0012239

Ejemplares similares